IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Tr

  • Company's PlaCCine\u00ae technology platform demonstrates better durability and other advantages compared to mRNA vaccines